HIV/HBV/HCV Test Kits Market

Top 2 Factors Shaping the HIV/HBV/HCV Test Kits Market

1. Rising Burden of HIV and Hepatitis around the World

   The rising incidence of HIV and hepatitis is expected to boost the growth of the HIV/HBV/HCV test kits market around the world. HIV is one of the major public health issues globally. In 2017, an estimated 36.9 Mn people were living with HIV, of which 1.8 Mn were found to be children. The hepatitis B infection affected most of the African and Western Pacific Regions.

   The prevalence of hepatitis C was found to be prominent in the eastern Mediterranean and European regions. Untreated hepatitis B and hepatitis C infections can lead to serious complications of hepatocellular carcinoma and cirrhosis, which accounts for 470,000 and 720,000 annual deaths respectively. This factor is boosting the patient pool and increasing the market growth of HIV/HBV/HCV test kits market.

2. Campaigns and Programme to Raise Awareness and Encourage People for HIV/HBV/HCV Testing

   A national communication campaign “HIV Treatment Works” encourages HIV patients to get and remain in care, start HIV medications, and follow treatment. This has contributed to the growth of the global HIV/HBV/HCV test kits market. The media team of American Institutes for Research closely works with CDC and provides nearly every major development regarding HIV/AIDS, STD, viral hepatitis, and tuberculosis to the population.

   The “We Can Stop HIV One Conversation at a Time” campaign encourages patients to talk independently about HIV. The campaign “Start Talking. Stop HIV”, raises awareness among bisexual men and gay. The governments, patient organizations, and the general public raised awareness regarding hepatitis and provided knowledge about disease prevention, access to testing, treatment, and care on “World Hepatitis Day”. These campaigns have largely contributed to the growth of the HIV/HBV/HCV test kits market.

HIV/HBV/HCV Test Kits Market Structure Analysis

• The global HIV/HBV/HCV test kits market is a moderately consolidated market owing to the presence of major players
• Some of the prominent companies in the HIV/HBV/HCV test kits market include Abbott Laboratories, Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., bioMérieux SA, QIAGEN, Meridian Bioscience, Inc., Hologic Inc., Siemens AG, Maternova, Creative Diagnostics, and others
• Most of the key players in the HIV/HBV/HCV test kits market are emphasising on identifying and developing promising technologies and potential products from internal and external sources to meet the unmet needs of patients
• The companies are focusing on collaborations to realise the potential of personalised healthcare as well as to enhance their pipeline in key disease areas

HIV/HBV/HCV Test Kits – Self-testing at Ease

Increasing efforts made by government and NGOs to raise awareness regarding HIV and viral hepatitis infections have worked to the advantage of the HIV/HBV/HCV test kits market. As new testing technologies and awareness campaigns have increased the uptake of HIV/HBV/HCV test kits among the patients, manufacturers are targeted towards developing innovative combination products that can detect HIV and hepatitis B & C together which can be next level of Hepatitis B Diagnostic Test and Hepatitis C Testing.

Market Set to Grow by 1.9X between 2019 and 2029

High prevalence of HIV and viral hepatitis infections, especially in low- and middle income countries, has been primarily contributing to the growth of the HIV/HBV/HCV test kits market. Future developments of the market are likely to go in hand with a global commitment to stop new infections and ensure that existing patients have access to advanced treatment.

Stakeholders to Tap Favourable Potential of Emerging Markets

Advanced healthcare systems, greater awareness among patients, and high demand for effective rapid diagnostic tests continue to make North America the largest market for HIV/HBV/HCV test kits. In addition to strengthening the product portfolios through R&D initiatives, key stakeholders are tapping into opportunities arising from low- and middle income countries where governments are employing prevention strategies of chronic diseases in association with WHO and CDC.

The Broader Perspective

Considering unmet needs of patients, manufacturers of HIV/HBV/HCV test kits are mainly focussed on discovery, development, and commercialization of innovative products. To stay competitive, market players are taking strategic initiatives to increase their product lines and expand their distribution in developing economies through acquisitions and collaborations with local distributors.

How Growth will Unfold

While assay-based test kits continue to maintain the lead position in the market, rapid test kits such as rapid test cards are expected to gain high popularity, for their ease of operations and quick results within two hours, typically in approximately 20 minutes.

HIV/HBV/HCV TEST KITS MARKET TAXONOMY

The global HIV/HBV/HCV test kits market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

By Kit Types

• HIV
  • Assay-Based Test Kits
  • Rapid Test Kits
• HBV
  • Assay-Based Test Kits
  • Rapid Test Kits
• HCV
  • Assay-Based Test Kits
  • Rapid Test Kits
• Combination Rapid Test Kits

By Sample Type

• For HIV, HBV, HCV and Combination Test Kits
  • Blood
  • Urine
  • Saliva

By End User

• For HIV, HBV, HCV and Combination Test Kits
  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Government Organizations and NGO’s
  • Others

Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa
• Emerging Countries